跳到正文
原文
STAT Pharma 医药频道· Meghana Keshavan·· 2026-10-01AI 评分20

STAT+: 近距离见证中国生物科技热潮

STAT+: A journey to witness China’s biotech boom up close

AI 导读

该订阅文章报道了美国卫生与公众服务部(HHS)希望利用AI革新临床试验,以及一名亨廷顿病患者对UniQure新数据反应平淡等生物科技行业新闻。

正文

HHS wants AI to reinvent clinical trials, a Huntington’s patient unfazed by new UniQure data, and more biotech news

A file news photo of the Shanghai skyline with the Huangpu river in the foreground
Jade Gao/AFP via Getty Images

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

I am newly enamored with Hans Zinsser, a Harvard bacteriologist who in 1935 wrote “Rats, Lice and History,” a rather charming “biography” of typhus. Got it for a buck at an estate sale.

Favorite line: “there is no arsphenamin for the psychic treponema” — which, in context, basically means, “pretension has no cure.”

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

  1. Biotech Correspondent

    Meghana Keshavan covers biotech and contributes to The Readout newsletter.

来源:STAT Pharma 医药频道 · statnews.com